Chào mừng trở lại
Tham gia Cointime
Đăng nhập với email
Đăng nhập với
Đăng ký
Arbor Pharmaceuticals
About
Arbor Pharmaceuticals is a specialty pharmaceutical company developing late-stage therapeutic products for common pediatric conditions.
- 501 - 1000
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $34.80M
- Industries
- Biotechnology,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2006
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Arbor Pharmaceuticals, operates as a specialty pharmaceutical company focusing on pediatric medicine. It engages in licensing, developing, and commercializing late-stage products for common pediatric conditions. The company's products include ZINOTIC and ZINOTIC ES, which addresses Acute Otitis Externa; NEOTIC, an otic analgesic agent for the treatment of pain and inflammation associated with Acute Otitis Media; and XYLAREX for the dietary management of Recurrent Acute Otitis Media. Its products also include Pediaderm HC Complete Kit, which is specifically developed to treat, manage, and protect the skin of children with atopic dermatitis, commonly referred to as eczema. The company markets its products specialty sales forces in the United States. Arbor Pharmaceuticals, was founded in 2006 and is based in Raleigh, North Carolina.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 4, 2014 | Private Equity（PE） | — | 1 |
Kohlberg Kravis Roberts
|
— | Detail |
| Nov 11, 2010 | Series B | $34.80M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Kohlberg Kravis Roberts
|
Yes | Private Equity（PE） |
|
|
— | Series B |
